Get started
Author

Mackenzie A. Hamilton

Individual and social determinants of SARS-CoV-2 testing and positivity in Ontario, Canada: a population-wide study
2021 · Maria E. Sundaram, Andrew Calzavara, et al. · Canadian Medical Association Journal · 117
PDF
Validating International Classification of Disease 10th Revision algorithms for identifying influenza and respiratory syncytial virus hospitalizations
2021 · Mackenzie A. Hamilton, Andrew Calzavara, et al. · PLoS ONE · 87
PDF
Predictors of all‐cause mortality among patients hospitalized with influenza, respiratory syncytial virus, or SARS‐CoV‐2
2022 · Mackenzie A. Hamilton, Ying Liu, et al. · Influenza and Other Respiratory Viruses · 38
Testing Whether Higher Contact Among the Vaccinated Can Be a Mechanism for Observed Negative Vaccine Effectiveness
2023 · Korryn Bodner, Jesse Knight, et al. · American Journal of Epidemiology · 16
PDF
Impact of a vaccine passport on first-dose SARS-CoV-2 vaccine coverage by age and area-level social determinants of health in the Canadian provinces of Quebec and Ontario: an interrupted time series analysis
2023 · Jorge Luis Flores Anato, Huiting Ma, et al. · CMAJ Open · 15
PDF
Examining the Influence of Imbalanced Social Contact Matrices in Epidemic Models
2023 · Mackenzie A Hamilton, Jesse Knight, et al. · American Journal of Epidemiology · 11
PDF
Characterizing the clinical and economic burden of COVID-19 among individuals with immunocompromising conditions in Ontario, Canada – a matched, population-based observational study
2025 · Christina Qian, Karissa M. Johnston, et al. · Journal of Medical Economics · 6
Adaptive data-driven age and patch mixing in contact networks with recurrent mobility
2021 · Jesse Knight, Huiting Ma, et al. · MethodsX · 4
PDF
Déterminants individuels et sociaux du test de dépistage du SRAS-CoV-2 et de l’obtention d’un résultat positif en Ontario, au Canada: une étude populationnelle
2021 · Maria E. Sundaram, Andrew Calzavara, et al. · Canadian Medical Association Journal · 3
PDF
Validating International Classification of Disease 10th revision algorithms for identifying influenza and respiratory syncytial virus hospitalizations
2021 · Mackenzie A Hamilton, Andrew Calzavara, et al. · University of Toronto Journal of Public Health · 1
Real‐World Treatment Patterns, Burden of Illness, and Survival of Autologous Stem Cell Transplant‐Ineligible Patients With Mantle Cell Lymphoma in Ontario, Canada
2026 · Sydney George, Soo Jin Seung, et al. · eJHaem
PDF
Late Breaking Abstract - Epidemiology and characteristics of Canadian adults with COPD who experience exacerbations while on inhaled triple therapy – An observational study of health administrative data
2026 · Mackenzie A Hamilton, Melissa L Woodward, et al. · European Respiratory Journal
An Observational Study of Patients With Chronic Lymphocytic Leukemia Treated With Fixed Duration Therapy in a 1L Setting in Canada
2026 · Carolyn Owen, Sydney George, et al. · Clinical Lymphoma Myeloma & Leukemia
Sustained asthma control and remission in real-world patients with severe eosinophilic asthma receiving benralizumab: XALOC-2
2026 · Marek Lommatzsch, Erika Penz, et al. · Journal of Asthma
Sustained asthma control and remission in real-world patients with severe eosinophilic asthma receiving benralizumab: XALOC-2
2026 · Marek Lommatzsch, Erika Penz, et al. · Figshare
Eph216 Mapping the Burden and Management of Asthma, Severe Asthma, and Eosinophilic Asthma Across Ontario, Canada
2026 · Ellie Joung, Mackenzie A. Hamilton, et al. · Value in Health
Treatment Patterns and Healthcare Resource Utilization of Pediatric Patients With Neurofibromatosis Type 1 and Unresectable Plexiform Neurofibromas in Canada
2026 · Sébastien Perreault, Craig Erker, et al. · Neuro-Oncology Pediatrics
Asthma control and clinical remission in severe eosinophilic asthma (SEA) after 2 years of benralizumab treatment: prospective real-world data from XALOC-2
2026 · M Lommatzsch, E Penz, et al. · Pneumologie
A genomic analysis of patients with chronic lymphocytic leukemia treated with fixed duration therapy in a first-line setting in alberta, Canada
2025 · Carolyn Owen, Sydney George, et al. · Blood
Asthma control and clinical remission in severe eosinophilic asthma (SEA) after 2 years of benralizumab treatment: prospective real-world data from XALOC-2
2025 · Marek Lommatzsch, Erika Penz, et al. · European Respiratory Journal
Asthma control and QoL among Canadian patients with severe eosinophilic asthma (SEA): 2-year real-world results
2025 · Erika Penz, Mackenzie Hamilton, et al. · European Respiratory Journal
Cost-effectiveness of integrated disease management for COPD in Ontario, Canada
2025 · Andrew Scarffe, Anna Hussey, et al. · European Respiratory Journal
EE410 Real-World Treatment Patterns, Clinical Outcomes, and Healthcare Resource Utilization of Patients with Chronic Lymphocytic Leukemia Treated with Fixed Duration Therapy in a First-Line Setting in Alberta, Canada
2025 · Sydney A. George, Sandra Thibault, et al. · Value in Health
Author response for "Predictors of all-cause mortality among patients hospitalized with influenza, respiratory syncytial virus, or SARS-CoV-2"
2022 · Hamilton, Mackenzie A., Liu, Ying, et al. · Publons reviews and discussion
Characteristics of a real world cohort of Canadians treated with benralizumab
2021 · Stephen G Noorduyn, Mackenzie A Hamilton, et al. · European Respiratory Journal
Works count: 26
Citation count: 298
H-index: 6
I10-index: 6
Year
Topic
Type